Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Year: 2015
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: lenvatinib, hepatocellular carcinoma, maximum tolerated dose, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, proteinuria, hepatic encephalopathy, hyperbilirubinemia, hypertension, c-kit-positive cells, endothelial cells, interleukin-6, vascular endothelial growth factor, granulocyte colony-stimulating factor, Child-Pugh score, tyrosine kinase inhibitors, antitumor efficacy
Open Access status: closed
Funder: Eisai
OpenAlex ID: W1834228192
